把三张表、经营指标、SEC / 巨潮 / 港交所原始财报、业绩材料和电话会放到同一条可核验时间线上。 披露事实、结构化补位值与派生指标分开标注，缺失逐字稿不会用摘要或模型生成内容补齐。
单季、累计、年度和资产负债表时点分开保存；每个数值都保留单位、申报日、表单、XBRL 概念或原始中文字段。
美股链接 SEC 法定申报和发行人 IR，A 股链接巨潮原始 PDF，港股链接港交所披露易原始年报与中报。分部、订单、产能和客户集中度只在有可核验披露时展示。
官方电话会入口与已授权逐字稿分开。没有合法取得的全文时只显示材料可用性，不生成或拼接虚假的逐字稿。
三张表会执行资产负债、毛利润、税前利润等勾稽检查；超出容差的记录保留原值并标记警告， 不会为了让公式“对上”而修改公司披露。
| 2026-06-30 |
| 3/3 |
| $3.16B |
| -$1.44B |
| -$44.9M |
| 32.8% |
| -66.3% |
| 86 |
| 尚无授权文本 |
| CWT CALIFORNIA WATER SERVICE GROUP | 2026-06-30 | 3/3 | $278.04M | $56.47M | — | — | 25.5% | 137 | 尚无授权文本 |
| EMN EASTMAN CHEMICAL CO | 2026-06-30 | 3/3 | $2.51B | $183M | -$116M | 22.3% | — | 85 | 尚无授权文本 |
| ESCA ESCALADE INC | 2026-06-30 | 3/3 | $57.7M | $9.43M | $13.53M | 26.2% | 20.7% | 76 | 尚无授权文本 |
| IONS IONIS PHARMACEUTICALS INC | 2026-06-30 | 3/3 | $267.95M | -$114.65M | -$265.13M | 99.0% | -38.2% | 120 | 尚无授权文本 |
| ISRG INTUITIVE SURGICAL INC | 2026-06-30 | 3/3 | $2.89B | $818.1M | — | 67.8% | 33.6% | 75 | 尚无授权文本 |
| KWR QUAKER CHEMICAL CORP | 2026-06-30 | 3/3 | $532.55M | $26.84M | $12.22M | 35.5% | 7.6% | 80 | 尚无授权文本 |
| MDGL MADRIGAL PHARMACEUTICALS, INC. | 2026-06-30 | 3/3 | $364.25M | -$57.94M | -$152.21M | — | -15.5% | 87 | 尚无授权文本 |
| MMSI MERIT MEDICAL SYSTEMS INC | 2026-06-30 | 3/3 | $418.84M | $38.8M | $76.62M | 51.4% | 14.4% | 83 | 尚无授权文本 |
| NVNO enVVeno Medical Corp | 2026-06-30 | 3/3 | — | -$3.6M | — | — | — | 57 | 尚无授权文本 |
| PHAT Phathom Pharmaceuticals, Inc. | 2026-06-30 | 3/3 | $74.27M | -$17.58M | -$17.68M | 79.7% | -5.3% | 113 | 尚无授权文本 |
| REGN REGENERON PHARMACEUTICALS, INC. | 2026-06-30 | 3/3 | $4.29B | $1.3B | — | — | 30.1% | 82 | 尚无授权文本 |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | 2026-06-30 | 3/3 | $4.14B | -$576M | — | 52.0% | -5.6% | 84 | 尚无授权文本 |
| WST WEST PHARMACEUTICAL SERVICES INC | 2026-06-30 | 3/3 | $872.3M | $154M | $128M | 37.7% | 20.5% | 77 | 尚无授权文本 |
| CALX CALIX, INC | 2026-06-27 | 3/3 | $293.33M | $17.11M | $18.45M | 54.6% | 7.4% | 75 | 尚无授权文本 |
| CALM CAL-MAINE FOODS INC | 2026-05-30 | 3/3 | $2.91B | $316.68M | $328.53M | 23.1% | 12.0% | 85 | 尚无授权文本 |
| CAL CALERES INC | 2026-05-02 | 3/3 | — | $14.28M | -$38.97M | — | — | 80 | 尚无授权文本 |
| KMTS KESTRA MEDICAL TECHNOLOGIES, LTD. | 2026-04-30 | 3/3 | $95.13M | -$131.61M | -$116.6M | 51.4% | -141.6% | 18 | 尚无授权文本 |
| OCC OPTICAL CABLE CORP | 2026-04-30 | 3/3 | — | $1.05M | -$1.57M | — | — | 65 | 尚无授权文本 |
| ZS Zscaler, Inc. | 2026-04-30 | 3/3 | $850.48M | -$13.88M | $772.9M | 77.3% | -3.5% | 66 | 尚无授权文本 |
| STAA STAAR SURGICAL CO | 2026-04-03 | 3/3 | $93.52M | $5.21M | -$22.14M | 73.6% | 8.5% | 125 | 尚无授权文本 |
| ABOS Acumen Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$20.74M | — | — | — | 72 | 尚无授权文本 |
| ACAD ACADIA PHARMACEUTICALS INC | 2026-03-31 | 3/3 | $268.06M | $3.64M | $28.77M | 90.8% | -1.7% | 83 | 尚无授权文本 |
| ACXP Acurx Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$1.68M | — | — | — | 56 | 尚无授权文本 |
| ADGM Adagio Medical Holdings, Inc. | 2026-03-31 | 3/3 | $0 | -$7M | -$4.13M | — | — | 40 | 尚无授权文本 |
| ADIL ADIAL PHARMACEUTICALS, INC. | 2026-03-31 | 3/3 | — | -$2.02M | — | — | — | 144 | 尚无授权文本 |
| AEMD AETHLON MEDICAL INC | 2026-03-31 | 3/3 | — | -$7.15M | -$7M | — | — | 97 | 尚无授权文本 |
| ALIS Calisa Acquisition Corp | 2026-03-31 | 3/3 | — | -$53,287 | — | — | — | 13 | 尚无授权文本 |
| ALISU Calisa Acquisition Corp | 2026-03-31 | 3/3 | — | -$53,287 | — | — | — | 13 | 尚无授权文本 |
| AMIX Autonomix Medical, Inc. | 2026-03-31 | 3/3 | $0 | -$16.72M | -$12.29M | — | — | 39 | 尚无授权文本 |
| AMLX Amylyx Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$41.28M | — | — | — | 68 | 尚无授权文本 |
| AMPH Amphastar Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | $171.17M | $6.42M | $38.33M | 41.1% | 8.0% | 81 | 尚无授权文本 |
| AMR Alpha Metallurgical Resources, Inc. | 2026-03-31 | 3/3 | $523.53M | -$11.03M | — | — | -2.0% | 112 | 尚无授权文本 |
| AMRX Amneal Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | $722.52M | $62.26M | -$34.92M | 44.3% | 19.6% | 87 | 尚无授权文本 |
| ANIP ANI PHARMACEUTICALS INC | 2026-03-31 | 3/3 | $237.46M | $29.49M | $52.3M | — | 16.4% | 115 | 尚无授权文本 |
| APUS Apimeds Pharmaceuticals US, Inc. | 2026-03-31 | 3/3 | — | -$35.06M | -$2.08M | — | — | 24 | 尚无授权文本 |
| APYX Apyx Medical Corp | 2026-03-31 | 3/3 | $12.49M | -$2.11M | -$632,000 | 63.5% | -7.3% | 90 | 尚无授权文本 |
| ARMP Armata Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$115.35M | -$5.85M | — | — | 97 | 尚无授权文本 |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | 2026-03-31 | 3/3 | $73.74M | -$132.73M | $93.21M | — | -191.6% | 86 | 尚无授权文本 |
| ATNM Actinium Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$5.52M | -$5.87M | — | — | 46 | 尚无授权文本 |
| AUPH Aurinia Pharmaceuticals Inc. | 2026-03-31 | 3/3 | $77.71M | $34.36M | — | 91.6% | 53.3% | 91 | 尚无授权文本 |
| AVIR Atea Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$45.44M | — | — | — | 63 | 尚无授权文本 |
| BANC BANC OF CALIFORNIA, INC. | 2026-03-31 | 3/3 | $10.11M | $71.95M | $45.6M | — | — | 91 | 尚无授权文本 |
| BCAL California BanCorp \ CA | 2026-03-31 | 3/3 | — | $13.79M | $8.3M | — | — | 48 | 尚无授权文本 |
| BCRX BIOCRYST PHARMACEUTICALS INC | 2026-03-31 | 3/3 | — | -$721.81M | — | — | — | 132 | 尚无授权文本 |
| BMRN BIOMARIN PHARMACEUTICAL INC | 2026-03-31 | 3/3 | $766.21M | $105.53M | $199.73M | 74.6% | 16.9% | 91 | 尚无授权文本 |
| CALC CalciMedica, Inc. | 2026-03-31 | 3/3 | — | $4.98M | -$4.86M | — | — | 88 | 尚无授权文本 |
| CALY Callaway Golf Co | 2026-03-31 | 3/3 | $687.5M | $93.1M | -$176M | 47.5% | 20.1% | 105 | 尚无授权文本 |
| CELZ CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | 2026-03-31 | 3/3 | $0 | -$1.41M | — | — | — | 60 | 尚无授权文本 |
| CHRN ChronoScale Holdings Corp | 2026-03-31 | 3/3 | — | -$6.89M | -$2.12M | — | — | 91 | 尚无授权文本 |
| CJMB CALLAN JMB INC. | 2026-03-31 | 3/3 | $1.11M | -$3.22M | -$1.72M | 38.6% | -153.8% | 21 | 尚无授权文本 |
| CLDI Calidi Biotherapeutics, Inc. | 2026-03-31 | 3/3 | — | -$4.11M | — | — | — | 120 | 尚无授权文本 |
| CLMT Calumet, Inc. /DE | 2026-03-31 | 3/3 | $1.03B | -$317M | -$99.4M | -8.5% | -16.6% | 47 | 尚无授权文本 |
| CNSP CNS Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$4.94M | -$4.65M | — | — | 108 | 尚无授权文本 |
| COCH Envoy Medical, Inc. | 2026-03-31 | 3/3 | $39,000 | -$4.35M | — | -702.6% | -15279.5% | 98 | 尚无授权文本 |
| COLL COLLEGIUM PHARMACEUTICAL, INC | 2026-03-31 | 3/3 | $193.52M | $14.5M | $56.84M | 60.6% | 16.0% | 94 | 尚无授权文本 |
| CPIX CUMBERLAND PHARMACEUTICALS INC | 2026-03-31 | 3/3 | $9.13M | -$3.29M | $387,025 | 78.8% | -34.3% | 98 | 尚无授权文本 |
| CRAQ Cal Redwood Acquisition Corp. | 2026-03-31 | 3/3 | — | $1.92M | — | — | — | 8 | 尚无授权文本 |
| CRAQU Cal Redwood Acquisition Corp. | 2026-03-31 | 3/3 | — | $1.92M | — | — | — | 8 | 尚无授权文本 |
| CRBP Corbus Pharmaceuticals Holdings, Inc. | 2026-03-31 | 3/3 | — | -$22.97M | -$25.58M | — | — | 118 | 尚无授权文本 |
| CRC California Resources Corp | 2026-03-31 | 3/3 | $905M | -$711M | -$32M | — | -78.6% | 111 | 尚无授权文本 |
| CRNX Crinetics Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | $10.73M | -$127.85M | -$125.52M | 98.1% | -1307.8% | 122 | 尚无授权文本 |
| CRVS Corvus Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$13.69M | -$10.47M | — | — | 87 | 尚无授权文本 |
| CTXR Citius Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | $1.67M | -$28.11M | — | 80.3% | -1931.0% | 137 | 尚无授权文本 |
| CURX Curanex Pharmaceuticals Inc | 2026-03-31 | 3/3 | — | -$3.15M | — | — | — | 14 | 尚无授权文本 |
| CWD CaliberCos Inc. | 2026-03-31 | 3/3 | $4.1M | -$3.62M | — | — | — | 122 | 尚无授权文本 |
| DERM Journey Medical Corp | 2026-03-31 | 3/3 | $15.92M | -$2.23M | — | 60.9% | -9.4% | 66 | 尚无授权文本 |
| DWSN DAWSON GEOPHYSICAL CO | 2026-03-31 | 3/3 | — | $7.66M | -$1.9M | — | — | 81 | 尚无授权文本 |
| ELDN Eledon Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$39.03M | — | — | — | 84 | 尚无授权文本 |
| ELOX Eloxx Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$3.75M | — | — | — | 81 | 尚无授权文本 |
| ENTA ENANTA PHARMACEUTICALS INC | 2026-03-31 | 3/3 | $17.16M | -$13.09M | -$19.01M | — | -69.1% | 76 | 尚无授权文本 |
| ETON Eton Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | $24.27M | $1.55M | $7.33M | 60.7% | 9.9% | 137 | 尚无授权文本 |
| FEED ENvue Medical, Inc. | 2026-03-31 | 3/3 | $653,000 | -$3.82M | -$4.33M | -8.4% | -568.3% | 133 | 尚无授权文本 |
| FENC FENNEC PHARMACEUTICALS INC. | 2026-03-31 | 3/3 | $15.11M | $201,000 | — | — | -0.8% | 80 | 尚无授权文本 |
| GMED GLOBUS MEDICAL INC | 2026-03-31 | 3/3 | $759.85M | $124.3M | $162.75M | 69.2% | 19.8% | 75 | 尚无授权文本 |
| GPUS Hyperscale Data, Inc. | 2026-03-31 | 3/3 | — | -$29.95M | -$10.76M | — | — | 281 | 尚无授权文本 |
| IBO IMPACT BIOMEDICAL INC. | 2026-03-31 | 3/3 | $7,000 | -$2.29M | — | — | -32700.0% | 27 | 尚无授权文本 |
| ICU SeaStar Medical Holding Corp | 2026-03-31 | 3/3 | $495,000 | -$3.52M | — | 90.7% | -727.9% | 125 | 尚无授权文本 |
| ICUI ICU MEDICAL INC/DE | 2026-03-31 | 3/3 | $530.23M | $30.13M | $27.61M | 38.9% | 2.6% | 68 | 尚无授权文本 |
| IIIV i3 Verticals, Inc. | 2026-03-31 | 3/3 | $57.52M | $1.46M | $23.43M | — | 6.5% | 70 | 尚无授权文本 |
| INDV Indivior Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | $317M | $89M | -$29M | 87.4% | 43.2% | 371 | 尚无授权文本 |
| INM InMed Pharmaceuticals Inc. | 2026-03-31 | 3/3 | — | -$2.97M | — | — | — | 188 | 尚无授权文本 |
| INO INOVIO PHARMACEUTICALS, INC. | 2026-03-31 | 3/3 | $0 | -$19.68M | -$21.59M | — | — | 76 | 尚无授权文本 |
| INSP Inspire Medical Systems, Inc. | 2026-03-31 | 3/3 | $204.58M | -$11.29M | $3.12M | 86.5% | -0.5% | 97 | 尚无授权文本 |
| IRWD IRONWOOD PHARMACEUTICALS INC | 2026-03-31 | 3/3 | $106.51M | $40.77M | — | — | 68.1% | 87 | 尚无授权文本 |
| JAZZ Jazz Pharmaceuticals plc | 2026-03-31 | 3/3 | $1.07B | $293.1M | $388.5M | — | 31.5% | 100 | 尚无授权文本 |
| KNSA Kiniksa Pharmaceuticals International, plc | 2026-03-31 | 3/3 | $214.27M | $22.59M | $50.04M | 90.3% | 13.7% | 80 | 尚无授权文本 |
| KPRX KIORA PHARMACEUTICALS INC | 2026-03-31 | 3/3 | — | -$2.42M | -$3.17M | — | — | 104 | 尚无授权文本 |
| KRMD KORU Medical Systems, Inc. | 2026-03-31 | 3/3 | $11.76M | -$807,078 | — | 61.5% | -7.4% | 80 | 尚无授权文本 |
| LBRX LB PHARMACEUTICALS INC | 2026-03-31 | 3/3 | — | -$19.05M | -$23.32M | — | — | 16 | 尚无授权文本 |
| LFCR LIFECORE BIOMEDICAL, INC. \DE\ | 2026-03-31 | 3/3 | — | -$14.98M | $3.58M | — | — | 120 | 尚无授权文本 |
| LGND LIGAND PHARMACEUTICALS INC | 2026-03-31 | 3/3 | $51.72M | -$13.35M | $48.46M | — | 33.6% | 110 | 尚无授权文本 |
| LOCL Local Bounti Corporation/DE | 2026-03-31 | 3/3 | $13.34M | -$12.72M | -$7.18M | 11.5% | -104.5% | 84 | 尚无授权文本 |
| LXRX LEXICON PHARMACEUTICALS, INC. | 2026-03-31 | 3/3 | $21.1M | -$1.04M | — | 99.5% | -4.7% | 101 | 尚无授权文本 |
| MBOT Microbot Medical Inc. | 2026-03-31 | 3/3 | $105,000 | -$3.67M | -$5.16M | 1.9% | -4114.3% | 225 | 尚无授权文本 |
| MD Pediatrix Medical Group, Inc. | 2026-03-31 | 3/3 | — | $29.57M | — | — | — | 79 | 尚无授权文本 |
| MGRX MANGOCEUTICALS, INC. | 2026-03-31 | 3/3 | $67,864 | -$3.4M | — | 42.7% | -4606.8% | 87 | 尚无授权文本 |
| MIRA MIRA PHARMACEUTICALS, INC. | 2026-03-31 | 3/3 | — | -$1.15M | — | — | — | 80 | 尚无授权文本 |
| MIRM Mirum Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | $159.88M | -$790.16M | -$229.43M | — | -493.8% | 96 | 尚无授权文本 |
| MIST Milestone Pharmaceuticals Inc. | 2026-03-31 | 3/3 | $238,000 | -$26.07M | -$16.1M | 94.1% | -9942.4% | 82 | 尚无授权文本 |
| MOBI Mobia Medical, Inc. | 2026-03-31 | 3/3 | $12.07M | -$17.74M | -$17.77M | 82.3% | -140.3% | 3 | 尚无授权文本 |
| MODD Modular Medical, Inc. | 2026-03-31 | 3/3 | — | -$28.24M | -$27.69M | — | — | 71 | 尚无授权文本 |
| MPT MEDICAL PROPERTIES TRUST INC | 2026-03-31 | 3/3 | $252.07M | $32.83M | — | 61.4% | — | 89 | 尚无授权文本 |
| NMTC NEUROONE MEDICAL TECHNOLOGIES Corp | 2026-03-31 | 3/3 | $1.86M | -$2.38M | -$4.52M | 53.2% | -128.7% | 100 | 尚无授权文本 |
| NRXP NRX Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | $1.07M | -$1.43M | — | 40.9% | -444.0% | 134 | 尚无授权文本 |
| OFIX Orthofix Medical Inc. | 2026-03-31 | 3/3 | $196.71M | -$20.91M | — | 70.9% | -7.3% | 95 | 尚无授权文本 |
| OLMA Olema Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$53.09M | — | — | — | 84 | 尚无授权文本 |
| OM Outset Medical, Inc. | 2026-03-31 | 3/3 | $27.86M | -$18.98M | -$12.91M | 43.4% | -60.7% | 87 | 尚无授权文本 |
| ORIC Oric Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$35.77M | -$32.44M | — | — | 84 | 尚无授权文本 |
| ORMP ORAMED PHARMACEUTICALS INC. | 2026-03-31 | 3/3 | — | $38.31M | -$2.92M | — | — | 104 | 尚无授权文本 |
| PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 2026-03-31 | 3/3 | $37.18M | -$8.28M | -$47.73M | 34.5% | -22.5% | 105 | 尚无授权文本 |
| PCSA Processa Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$3.38M | — | — | — | 116 | 尚无授权文本 |
| PHIO Phio Pharmaceuticals Corp. | 2026-03-31 | 3/3 | — | -$4M | -$4M | — | — | 114 | 尚无授权文本 |
| PMVP PMV Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$18.04M | -$19.68M | — | — | 65 | 尚无授权文本 |
| PROF Profound Medical Corp. | 2026-03-31 | 3/3 | $5.34M | -$7.05M | — | 71.8% | -150.3% | 164 | 尚无授权文本 |
| QNRX Quoin Pharmaceuticals, Ltd. | 2026-03-31 | 3/3 | — | -$5M | — | — | — | 118 | 尚无授权文本 |
| RARE Ultragenyx Pharmaceutical Inc. | 2026-03-31 | 3/3 | $136M | -$185M | -$198M | — | -124.3% | 119 | 尚无授权文本 |
| RCEL AVITA Medical, Inc. | 2026-03-31 | 3/3 | $19.25M | -$10.61M | -$10.09M | 81.7% | -45.7% | 122 | 尚无授权文本 |
| RCKT ROCKET PHARMACEUTICALS, INC. | 2026-03-31 | 3/3 | $0 | -$47.59M | -$45.49M | — | — | 97 | 尚无授权文本 |
| RIGL RIGEL PHARMACEUTICALS INC | 2026-03-31 | 3/3 | $58.82M | $8.65M | — | 92.2% | 20.2% | 94 | 尚无授权文本 |
| RMTI ROCKWELL MEDICAL, INC. | 2026-03-31 | 3/3 | — | -$1.61M | — | — | — | 105 | 尚无授权文本 |
| RTAC Renatus Tactical Acquisition Corp I | 2026-03-31 | 3/3 | — | $1.81M | — | — | — | 10 | 尚无授权文本 |
| RTACU Renatus Tactical Acquisition Corp I | 2026-03-31 | 3/3 | — | $1.81M | — | — | — | 10 | 尚无授权文本 |
| RXRX RECURSION PHARMACEUTICALS, INC. | 2026-03-31 | 3/3 | $6.47M | -$117.5M | -$81.36M | -93.0% | -1985.6% | 103 | 尚无授权文本 |
| RYTM RHYTHM PHARMACEUTICALS, INC. | 2026-03-31 | 3/3 | $60.11M | -$55.64M | — | 88.1% | -87.1% | 98 | 尚无授权文本 |
| SBC SBC Medical Group Holdings Inc | 2026-03-31 | 3/3 | $43.06M | $11.31M | $9.11M | 70.5% | 41.2% | 61 | 尚无授权文本 |
| SHPH Shuttle Pharmaceuticals Holdings, Inc. | 2026-03-31 | 3/3 | — | -$2.15M | — | — | — | 109 | 尚无授权文本 |
| SMR NUSCALE POWER Corp | 2026-03-31 | 3/3 | $565,000 | -$44.02M | -$316.2M | 3.7% | -10181.2% | 128 | 尚无授权文本 |
| SNDX Syndax Pharmaceuticals Inc | 2026-03-31 | 3/3 | $64.86M | -$42.67M | — | — | -52.7% | 91 | 尚无授权文本 |
| SNOA Sonoma Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | $19.53M | -$3.18M | -$4.13M | 38.0% | -12.6% | 89 | 尚无授权文本 |
| SPRY ARS Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | $22.68M | -$60.62M | -$44.95M | — | -265.2% | 87 | 尚无授权文本 |
| SRTA Strata Critical Medical, Inc. | 2026-03-31 | 3/3 | $67.38M | $2.15M | -$1.29M | 21.0% | -4.4% | 76 | 尚无授权文本 |
| SUPN SUPERNUS PHARMACEUTICALS, INC. | 2026-03-31 | 3/3 | $207.71M | -$2.29M | $66.52M | 88.7% | -4.0% | 142 | 尚无授权文本 |
| SXTC China SXT Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$6.21M | — | — | — | 46 | 尚无授权文本 |
| SXTP 60 DEGREES PHARMACEUTICALS, INC. | 2026-03-31 | 3/3 | $162,092 | -$2.09M | -$2.77M | 47.1% | -1292.5% | 54 | 尚无授权文本 |
| TARS Tarsus Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | $162.05M | -$6.97M | -$30.47M | 94.2% | -3.8% | 89 | 尚无授权文本 |
| TELO Telomir Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$990,947 | — | — | — | 68 | 尚无授权文本 |
| TMCI TREACE MEDICAL CONCEPTS, INC. | 2026-03-31 | 3/3 | $47.2M | -$17.96M | $4.18M | 79.3% | -36.4% | 67 | 尚无授权文本 |
| TNON Tenon Medical, Inc. | 2026-03-31 | 3/3 | $1.38M | -$3.48M | -$3.02M | 68.5% | -237.9% | 65 | 尚无授权文本 |
| TNXP Tonix Pharmaceuticals Holding Corp. | 2026-03-31 | 3/3 | $6.88M | -$40.19M | -$44.01M | 77.1% | -603.9% | 393 | 尚无授权文本 |
| USPH U S PHYSICAL THERAPY INC /NV | 2026-03-31 | 3/3 | $198.29M | $5.04M | — | 16.5% | 6.3% | 179 | 尚无授权文本 |
| UTI UNIVERSAL TECHNICAL INSTITUTE INC | 2026-03-31 | 3/3 | $221.4M | $433,000 | -$45.59M | — | 0.2% | 81 | 尚无授权文本 |
| UTMD UTAH MEDICAL PRODUCTS INC | 2026-03-31 | 3/3 | $8.72M | $2.6M | $2.98M | 60.6% | 29.4% | 63 | 尚无授权文本 |
| VANI Vivani Medical, Inc. | 2026-03-31 | 3/3 | — | -$6.78M | -$6.2M | — | — | 113 | 尚无授权文本 |
| VNDA Vanda Pharmaceuticals Inc. | 2026-03-31 | 3/3 | $51.72M | -$48.57M | -$50.44M | — | -97.1% | 99 | 尚无授权文本 |
| VRCA Verrica Pharmaceuticals Inc. | 2026-03-31 | 3/3 | $5.02M | -$9.68M | — | — | -193.4% | 103 | 尚无授权文本 |
| VRTX VERTEX PHARMACEUTICALS INC / MA | 2026-03-31 | 3/3 | $2.99B | $1.03B | $1.29B | 86.8% | 38.1% | 72 | 尚无授权文本 |
| WLKP Westlake Chemical Partners LP | 2026-03-31 | 3/3 | $305.68M | $14.17M | $104.64M | 30.7% | 28.3% | 57 | 尚无授权文本 |
| XENE Xenon Pharmaceuticals Inc. | 2026-03-31 | 3/3 | — | -$102.3M | -$89.03M | — | — | 90 | 尚无授权文本 |
| XFOR X4 Pharmaceuticals, Inc | 2026-03-31 | 3/3 | $2.71M | -$20.24M | — | 77.9% | -749.9% | 123 | 尚无授权文本 |
| XTNT Xtant Medical Holdings, Inc. | 2026-03-31 | 3/3 | $20.88M | -$3.09M | -$2.31M | 57.3% | -14.0% | 94 | 尚无授权文本 |
| ZNTL Zentalis Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$35.35M | -$32.99M | — | — | 108 | 尚无授权文本 |
| ATCX ATLAS CRITICAL MINERALS Corp | 2025-12-31 | 3/3 | $92,491 | -$5.42M | -$3.79M | -64.3% | -5787.6% | 20 | 尚无授权文本 |
| BDMD Baird Medical Investment Holdings Ltd | 2025-12-31 | 3/3 | $22.54M | -$27.28M | -$1.39M | 83.8% | -113.7% | 7 | 尚无授权文本 |
| BDRX Biodexa Pharmaceuticals Plc | 2025-12-31 | 2/3 | — | -$6.38M | — | — | — | 141 | 尚无授权文本 |
| CCM Concord Medical Services Holdings Ltd | 2025-12-31 | 3/3 | $454.33M | -$92.81M | -$36.92M | 5.7% | -57.6% | 59 | 尚无授权文本 |
| CRML Critical Metals Corp. | 2025-12-31 | 2/3 | — | -$120.38M | — | — | — | 43 | 尚无授权文本 |
| DLO dLocal Ltd | 2025-12-31 | 2/3 | — | $196.9M | — | — | — | 58 | 尚无授权文本 |
| DRTS Alpha Tau Medical Ltd. | 2025-12-31 | 3/3 | — | -$42.63M | -$32.76M | — | — | 123 | 尚无授权文本 |
| EPRX EUPRAXIA PHARMACEUTICALS INC. | 2025-12-31 | 3/3 | $0 | -$38.58M | — | — | — | 84 | 尚无授权文本 |
| EVTL Vertical Aerospace Ltd. | 2025-12-31 | 2/3 | — | $232.93M | — | — | — | 97 | 尚无授权文本 |
| FMS Fresenius Medical Care AG | 2025-12-31 | 2/3 | — | $1.19B | — | — | — | 124 | 尚无授权文本 |
| GLMD Galmed Pharmaceuticals Ltd. | 2025-12-31 | 3/3 | — | -$10.31M | — | — | — | 125 | 尚无授权文本 |
| ICCM IceCure Medical Ltd. | 2025-12-31 | 3/3 | $3.38M | -$15.06M | -$14.61M | 36.3% | -446.7% | 172 | 尚无授权文本 |
| TLX Telix Pharmaceuticals Ltd | 2025-12-31 | 2/3 | — | -$7.13M | — | — | — | 57 | 尚无授权文本 |
| BYAH Park Ha Biological Technology Co., Ltd. | 2025-10-31 | 3/3 | $2.52M | -$24.36M | — | 94.4% | -956.5% | 29 | 尚无授权文本 |
| PASW Ping An Biomedical Co., Ltd. | 2025-09-30 | 3/3 | $34.15M | -$12.83M | — | 2.8% | -43.1% | 16 | 尚无授权文本 |
| PBM PSYENCE BIOMEDICAL LTD. | 2025-09-30 | 2/3 | — | -$753,254 | — | — | — | 59 | 尚无授权文本 |
| UPC Universe Pharmaceuticals INC | 2025-09-30 | 3/3 | $17.86B | -$3.67B | -$5.32B | 35.3% | -16.3% | 52 | 尚无授权文本 |
| WOK WORK Medical Technology Group LTD | 2025-09-30 | 3/3 | — | -$1.07M | $4.91M | — | — | 29 | 尚无授权文本 |
| ZJYL Jin Medical International Ltd. | 2025-09-30 | 3/3 | $20.69M | $1.19M | -$3.73M | 29.2% | 2.9% | 43 | 尚无授权文本 |
| BMGL Basel Medical Group Ltd | 2025-06-30 | 2/3 | — | -$10.64M | — | — | — | 28 | 尚无授权文本 |
| TAK TAKEDA PHARMACEUTICAL CO LTD | 2025-03-31 | 2/3 | — | $108.14B | — | — | — | 272 | 尚无授权文本 |
| CMCL Caledonia Mining Corp Plc | 2024-12-31 | 2/3 | — | $23.05M | — | — | — | 357 | 尚无授权文本 |
| SQM CHEMICAL & MINING CO OF CHILE INC | 2024-12-31 | 2/3 | — | $691.84M | — | — | — | 179 | 尚无授权文本 |
| XTLB XTL BIOPHARMACEUTICALS LTD | 2024-12-31 | 2/3 | — | -$1.03M | — | — | — | 75 | 尚无授权文本 |
| BIOT INSTINCT BIO TECHNICAL CO HOLDINGS INC. | — | 0/3 | — | — | — | — | — | 4 | 尚无授权文本 |
| CCD Calamos Dynamic Convertible & Income Fund | — | 0/3 | — | — | — | — | — | 3 | 尚无授权文本 |
| CEV Eaton Vance California Municipal Income Trust | — | 0/3 | — | — | — | — | — | 9 | 尚无授权文本 |
| CGO CALAMOS GLOBAL TOTAL RETURN FUND | — | 0/3 | — | — | — | — | — | 3 | 尚无授权文本 |
| CHI CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND | — | 0/3 | — | — | — | — | — | 3 | 尚无授权文本 |
| CHW Calamos Global Dynamic Income Fund | — | 0/3 | — | — | — | — | — | 3 | 尚无授权文本 |
| CHY CALAMOS CONVERTIBLE & HIGH INCOME FUND | — | 0/3 | — | — | — | — | — | 3 | 尚无授权文本 |
| CPZ Calamos Long/Short Equity & Dynamic Income Trust | — | 0/3 | — | — | — | — | — | 2 | 尚无授权文本 |
| CSQ CALAMOS STRATEGIC TOTAL RETURN FUND | — | 0/3 | — | — | — | — | — | 3 | 尚无授权文本 |
| MUC BLACKROCK MUNIHOLDINGS CALIFORNIA QUALITY FUND, INC. | — | 0/3 | — | — | — | — | — | 2 | 尚无授权文本 |
| NAC Nuveen California Quality Municipal Income Fund | — | 0/3 | — | — | — | — | — | 4 | 尚无授权文本 |
| NCA NUVEEN CALIFORNIA MUNICIPAL VALUE FUND | — | 0/3 | — | — | — | — | — | 3 | 尚无授权文本 |
| NKX NUVEEN CALIFORNIA AMT-FREE QUALITY MUNICIPAL INCOME FUND | — | 0/3 | — | — | — | — | — | 4 | 尚无授权文本 |
| PCQ PIMCO CALIFORNIA MUNICIPAL INCOME FUND | — | 0/3 | — | — | — | — | — | 7 | 尚无授权文本 |
| VCV Invesco California Value Municipal Income Trust | — | 0/3 | — | — | — | — | — | 0 | 尚无授权文本 |